Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Do cells let-7 determine stemness?

Dröge P, Davey CA.

Cell Stem Cell. 2008 Jan 10;2(1):8-9. doi: 10.1016/j.stem.2007.12.003.

2.

LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells.

Zhou J, Ng SB, Chng WJ.

Int J Biochem Cell Biol. 2013 May;45(5):973-8. doi: 10.1016/j.biocel.2013.02.006. Review.

PMID:
23420006
3.

HMGA2 and high-grade serous ovarian carcinoma.

Wu J, Wei JJ.

J Mol Med (Berl). 2013 Oct;91(10):1155-65. doi: 10.1007/s00109-013-1055-8. Review.

PMID:
23686260
4.

Roles of microRNAs in cancer stem cells.

Zhou N, Mo YY.

Front Biosci (Schol Ed). 2012 Jan 1;4:810-8. Review.

PMID:
22202092
5.

Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy.

Leal JA, Feliciano A, Lleonart ME.

Med Res Rev. 2013 Jan;33(1):112-38. doi: 10.1002/med.20246. Review.

PMID:
21793013
6.
7.

HMGA2, microRNAs, and stem cell aging.

Hammond SM, Sharpless NE.

Cell. 2008 Dec 12;135(6):1013-6. doi: 10.1016/j.cell.2008.11.026. Review.

8.

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Xia H, Hui KM.

Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Review.

PMID:
22975591
9.

Oncogenic roles of EMT-inducing transcription factors.

Puisieux A, Brabletz T, Caramel J.

Nat Cell Biol. 2014 Jun;16(6):488-94. doi: 10.1038/ncb2976. Review.

PMID:
24875735
10.

The role of let-7 in cell differentiation and cancer.

Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME.

Endocr Relat Cancer. 2010 Jan 29;17(1):F19-36. doi: 10.1677/ERC-09-0184. Review.

11.

[Epithelial-mesenchymal transition and cancer stem cells].

Zou DD, Tang XB.

Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):62-5. doi: 10.3760/cma.j.issn.0529-5807.2013.01.018. Review. Chinese. No abstract available.

PMID:
23611281
12.

The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.

Gao X, Jin W.

Cancer Lett. 2014 Oct 10;353(1):25-31. doi: 10.1016/j.canlet.2014.07.011. Review.

PMID:
25042866
13.

Therapeutic potential of microRNA let-7: tumor suppression or impeding normal stemness.

Chiu SC, Chung HY, Cho DY, Chan TM, Liu MC, Huang HM, Li TY, Lin JY, Chou PC, Fu RH, Yang WK, Harn HJ, Lin SZ.

Cell Transplant. 2014;23(4-5):459-69. doi: 10.3727/096368914X678418. Review.

PMID:
24816444
14.

MicroRNAs: regulators of oncogenesis and stemness.

Papagiannakopoulos T, Kosik KS.

BMC Med. 2008 Jun 24;6:15. doi: 10.1186/1741-7015-6-15. Review.

15.

Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?

Gunaratne PH.

Curr Stem Cell Res Ther. 2009 Sep;4(3):168-77. Review.

PMID:
19492978
16.

Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.

Natarajan TG, Ganesan N, Fitzgerald KT.

Cancer Biomark. 2010;9(1-6):65-99. doi: 10.3233/CBM-2011-0173. Review.

PMID:
22112470
17.

Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z.

RNA. 2009 Aug;15(8):1443-61. doi: 10.1261/rna.1534709. Review.

18.

Emerging roles for modulation of microRNA signatures in cancer chemoprevention.

Neelakandan K, Babu P, Nair S.

Curr Cancer Drug Targets. 2012 Jul;12(6):716-40. Review.

PMID:
22515522
19.

miRNAs highlights in stem and cancer cells.

Martignani E, Miretti S, Accornero P, Baratta M.

Mini Rev Med Chem. 2011 Nov;11(13):1165-82. Review.

PMID:
22353225
20.

[MicroRNA and cancer].

Kiselev FL.

Mol Biol (Mosk). 2014 Mar-Apr;48(2):232-42. Review. Russian.

PMID:
25850292

Supplemental Content

Support Center